Personal pain action plans for children and adolescents with sickle cell disease

Melissa J Frei-jones, Michael R. DeBaun

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Children and adolescents with Sickle Cell Disease [SCD] frequently experience pain, limiting normal activities such as school attendance, work or play. Most pain episodes are managed at home; although, many children require hospitalization. The episodic and unpredictable nature of SCD-related pain requires patient and caregiver recognition of impending pain and implementation of patient specific treatment to relieve and abate symptoms. Pediatric asthma action plans are standard in the management of chronic asthma care, having been included in both national and international standards for pediatric asthma management for more than a decade. The use of Asthma Action Plans in childhood asthma has improved the outpatient management of symptoms and exacerbations while also reducing the frequency of emergency department visits and hospitalizations. Despite the recognized utility of treatment action plans in chronic disease, no systematic action plan has been developed for the treatment of SCD-related pain. We developed a SCD-specific pain action plan [PAP] to promote patient and caregiver education and self-management strategies that are required for successful ongoing treatment. Every child with SCD is required to have a PAP developed, reviewed and revised at each hematology visit. A PAP is implemented in children as young as six months of age before symptoms appeared. In this commentary, we introduce the theoretical basis for to support a patient SCD PAP and describe the benefit and barriers associated with developing and implementing a PAP for children with SCD in a single center. We also identify opportunities for future research to assess the clinical utility of a PAP in SCD.

Original languageEnglish (US)
Title of host publicationAcute Pain: Causes, Effects And Treatment
PublisherNova Science Publishers, Inc.
Pages213-220
Number of pages8
ISBN (Print)9781607412236
StatePublished - 2009

Fingerprint

Sickle Cell Anemia
Pain
Asthma
Caregivers
Hospitalization
Pediatrics
Hematology
Patient Education
Therapeutics
Self Care
Hospital Emergency Service
Chronic Disease
Outpatients

Keywords

  • Children
  • Pain
  • Sickle cell disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Frei-jones, M. J., & DeBaun, M. R. (2009). Personal pain action plans for children and adolescents with sickle cell disease. In Acute Pain: Causes, Effects And Treatment (pp. 213-220). Nova Science Publishers, Inc..

Personal pain action plans for children and adolescents with sickle cell disease. / Frei-jones, Melissa J; DeBaun, Michael R.

Acute Pain: Causes, Effects And Treatment. Nova Science Publishers, Inc., 2009. p. 213-220.

Research output: Chapter in Book/Report/Conference proceedingChapter

Frei-jones, MJ & DeBaun, MR 2009, Personal pain action plans for children and adolescents with sickle cell disease. in Acute Pain: Causes, Effects And Treatment. Nova Science Publishers, Inc., pp. 213-220.
Frei-jones MJ, DeBaun MR. Personal pain action plans for children and adolescents with sickle cell disease. In Acute Pain: Causes, Effects And Treatment. Nova Science Publishers, Inc. 2009. p. 213-220
Frei-jones, Melissa J ; DeBaun, Michael R. / Personal pain action plans for children and adolescents with sickle cell disease. Acute Pain: Causes, Effects And Treatment. Nova Science Publishers, Inc., 2009. pp. 213-220
@inbook{404625da009442c6990b4b23ec23a60d,
title = "Personal pain action plans for children and adolescents with sickle cell disease",
abstract = "Children and adolescents with Sickle Cell Disease [SCD] frequently experience pain, limiting normal activities such as school attendance, work or play. Most pain episodes are managed at home; although, many children require hospitalization. The episodic and unpredictable nature of SCD-related pain requires patient and caregiver recognition of impending pain and implementation of patient specific treatment to relieve and abate symptoms. Pediatric asthma action plans are standard in the management of chronic asthma care, having been included in both national and international standards for pediatric asthma management for more than a decade. The use of Asthma Action Plans in childhood asthma has improved the outpatient management of symptoms and exacerbations while also reducing the frequency of emergency department visits and hospitalizations. Despite the recognized utility of treatment action plans in chronic disease, no systematic action plan has been developed for the treatment of SCD-related pain. We developed a SCD-specific pain action plan [PAP] to promote patient and caregiver education and self-management strategies that are required for successful ongoing treatment. Every child with SCD is required to have a PAP developed, reviewed and revised at each hematology visit. A PAP is implemented in children as young as six months of age before symptoms appeared. In this commentary, we introduce the theoretical basis for to support a patient SCD PAP and describe the benefit and barriers associated with developing and implementing a PAP for children with SCD in a single center. We also identify opportunities for future research to assess the clinical utility of a PAP in SCD.",
keywords = "Children, Pain, Sickle cell disease",
author = "Frei-jones, {Melissa J} and DeBaun, {Michael R.}",
year = "2009",
language = "English (US)",
isbn = "9781607412236",
pages = "213--220",
booktitle = "Acute Pain: Causes, Effects And Treatment",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Personal pain action plans for children and adolescents with sickle cell disease

AU - Frei-jones, Melissa J

AU - DeBaun, Michael R.

PY - 2009

Y1 - 2009

N2 - Children and adolescents with Sickle Cell Disease [SCD] frequently experience pain, limiting normal activities such as school attendance, work or play. Most pain episodes are managed at home; although, many children require hospitalization. The episodic and unpredictable nature of SCD-related pain requires patient and caregiver recognition of impending pain and implementation of patient specific treatment to relieve and abate symptoms. Pediatric asthma action plans are standard in the management of chronic asthma care, having been included in both national and international standards for pediatric asthma management for more than a decade. The use of Asthma Action Plans in childhood asthma has improved the outpatient management of symptoms and exacerbations while also reducing the frequency of emergency department visits and hospitalizations. Despite the recognized utility of treatment action plans in chronic disease, no systematic action plan has been developed for the treatment of SCD-related pain. We developed a SCD-specific pain action plan [PAP] to promote patient and caregiver education and self-management strategies that are required for successful ongoing treatment. Every child with SCD is required to have a PAP developed, reviewed and revised at each hematology visit. A PAP is implemented in children as young as six months of age before symptoms appeared. In this commentary, we introduce the theoretical basis for to support a patient SCD PAP and describe the benefit and barriers associated with developing and implementing a PAP for children with SCD in a single center. We also identify opportunities for future research to assess the clinical utility of a PAP in SCD.

AB - Children and adolescents with Sickle Cell Disease [SCD] frequently experience pain, limiting normal activities such as school attendance, work or play. Most pain episodes are managed at home; although, many children require hospitalization. The episodic and unpredictable nature of SCD-related pain requires patient and caregiver recognition of impending pain and implementation of patient specific treatment to relieve and abate symptoms. Pediatric asthma action plans are standard in the management of chronic asthma care, having been included in both national and international standards for pediatric asthma management for more than a decade. The use of Asthma Action Plans in childhood asthma has improved the outpatient management of symptoms and exacerbations while also reducing the frequency of emergency department visits and hospitalizations. Despite the recognized utility of treatment action plans in chronic disease, no systematic action plan has been developed for the treatment of SCD-related pain. We developed a SCD-specific pain action plan [PAP] to promote patient and caregiver education and self-management strategies that are required for successful ongoing treatment. Every child with SCD is required to have a PAP developed, reviewed and revised at each hematology visit. A PAP is implemented in children as young as six months of age before symptoms appeared. In this commentary, we introduce the theoretical basis for to support a patient SCD PAP and describe the benefit and barriers associated with developing and implementing a PAP for children with SCD in a single center. We also identify opportunities for future research to assess the clinical utility of a PAP in SCD.

KW - Children

KW - Pain

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=84892065084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892065084&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84892065084

SN - 9781607412236

SP - 213

EP - 220

BT - Acute Pain: Causes, Effects And Treatment

PB - Nova Science Publishers, Inc.

ER -